New views on natural killer cell-based immunotherapy for melanoma treatment.
about
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective ImmunotherapyThe pre-metastatic niche: finding common ground.Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patientsThe Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing.The human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitroEnhanced Anti-Cancer Effect of Snake Venom Activated NK Cells on Lung Cancer Cells by Inactivation of NF-κBNovel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.Mechanisms of NK cell activation: CD4(+) T cells enter the scene.Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas.Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Effect of tumor cells and tumor microenvironment on NK-cell function.Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.Role of NK cells in immunotherapy and virotherapy of solid tumors.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.The immune system and cancer evasion strategies: therapeutic concepts.Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretionCo-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB.Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibody.TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma.Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation.IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid.Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients.
P2860
Q26746478-A83812F2-AD99-4DAE-A8D9-191C3AA2F5F3Q26771449-9D605BD4-749F-4E7A-ACEF-0E5FF848A691Q34342357-EF7EEDFF-66A2-468B-97B4-99E548513502Q35114206-BEBCD2BC-5605-4473-9D3A-A85B1124203DQ36093080-BD83E7EE-9661-4178-80CC-379886CB8048Q36160553-07C266D6-4703-481D-A304-BBE747BFA9B6Q37684206-E81FD883-4810-4203-9A8D-652323C27E0FQ37737545-50975C63-0F72-46FB-A9B2-69C0DABCF3B2Q37876096-6A240211-2D66-4B1D-91A8-E057884F5B91Q37921196-67162E84-8464-4F9C-9022-A6A3A82B1F6EQ37952245-E21FC7A2-1C9E-410A-9B55-0179CEB11BAAQ37952804-FD792C15-C8A6-4534-814C-46D18897DCFAQ38151057-4ACB8DD6-041E-4B2B-A7BC-FD2D97A97069Q38207947-4FFCDD2E-F161-4CD6-8DB4-43F2BD58DB0BQ38569646-F9B47064-0C30-4782-8EC6-8CFE9F8FCCE9Q38575116-B2F80C05-1448-4A75-8C13-CBD7A96EC9EAQ38670431-866C4437-3005-48DF-B23E-29EC3AE3B171Q38685785-635BDFA6-047F-4775-938C-CA8BDD723D3AQ38691172-6A7C3BFA-F9DE-4438-9A00-0D54860D0917Q38706890-F3730076-C53F-49D7-AD4B-9E78BB291A9CQ39038239-FA38848C-6D4B-47DC-802C-5B5C3FF1AE08Q39085019-FFA493BF-C98A-4EF5-BD12-FA8508B4B805Q42008502-16CE29AB-198D-440B-BF51-3D1A9022E205Q46897065-135E55BE-3918-4194-9B4E-540D0C70E034Q50644902-5EC008AD-EBF3-4754-8058-31F9E05682ABQ55673215-FB0A4CC1-B912-4B15-BB20-936AD7337EF3
P2860
New views on natural killer cell-based immunotherapy for melanoma treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New views on natural killer cell-based immunotherapy for melanoma treatment.
@en
New views on natural killer cell-based immunotherapy for melanoma treatment.
@nl
type
label
New views on natural killer cell-based immunotherapy for melanoma treatment.
@en
New views on natural killer cell-based immunotherapy for melanoma treatment.
@nl
prefLabel
New views on natural killer cell-based immunotherapy for melanoma treatment.
@en
New views on natural killer cell-based immunotherapy for melanoma treatment.
@nl
P356
P1433
P1476
New views on natural killer cell-based immunotherapy for melanoma treatment
@en
P2093
Shannon Burke
Tadepally Lakshmikanth
P304
P356
10.1016/J.IT.2010.06.003
P577
2010-07-23T00:00:00Z